EEG patterns as an index of clinical activity of psychoactive drugs.
D000654:Amobarbital / Q000627:therapeutic use; D001067:Appetite Depressants / Q000627:therapeutic use; D001337:Autonomic Agents / Q000627:therapeutic use*; D001463:Barbiturates / Q000627:therapeutic use; D002698:Chloralose / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D003496:Cyclazocine / Q000627:therapeutic use; D003913:Dextroamphetamine / Q000627:therapeutic use; D004569:Electroencephalography; D005071:Evoked Potentials; D005277:Fenfluramine / Q000627:therapeutic use; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use; D014272:Trifluperidol / Q000627:therapeutic use; D014966:Xanthenes / Q000627:therapeutic use
D001067:Appetite Depressants; D001337:Autonomic Agents; D001463:Barbiturates; D010276:Parasympatholytics; D013566:Sympathomimetics; D014966:Xanthenes; D002698:Chloralose; D005277:Fenfluramine; D000654:Amobarbital; D003496:Cyclazocine; D007099:Imipramine; D014272:Trifluperidol; D003913:Dextroamphetamine; D002746:Chlorpromazine